Our study reveals an ability of PKCα to directly interact with Nox5 and regulate its activity which may provide as an important mechanism by which inhibition of PKCα protects against cardiovascular disease, including heart failure, myocardial infarction, and coronary artery diseases. This evidence concerns the gene PRKCA and heart failure.